Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) Antibody

Este producto es parte de CTLA4 - cytotoxic T-lymphocyte associated protein 4
Product Graph
299€ (0.1 mg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx139385
tested applications
IHC, IF/ICC, FCM, IP

Description

CD152 Antibody is a Mouse Monoclonal against CD152.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4)
Host
Mouse
Reactivity
Human
Recommended Dilution
FCM: 1-4 µg/ml. Suitable for use in IHC-F, not tested in IHC-P. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG2a
Clone ID
H347
Purity
> 95% (SDS-PAGE)
Purification
Purified by Protein A affinity chromatography.
Size 1
0.1 mg
Tested Applications
IHC, IF/ICC, FCM, IP
Buffer
PBS solution with 15 mM sodium azide.
Availability
Shipped within 5-12 working days.
Storage
Store at 2-8°C. Do not freeze.
Dry Ice
No
UniProt ID
P16410
Gene ID
1493
Alias
Cytotoxic T-lymphocyte protein 4,CD,GSE,GRD4,ALPS5,CD152,Cytotoxic T-lymphocyte-associated antigen 4,CTLA-4,IDDM12,CELIAC3,
Background
Antibody anti-CTLA4
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

Cytotoxic T-lymphocyte associated protein 4 (CTLA-4), encoded by the CTLA4 gene on chromosome 2, is an essential immune checkpoint receptor primarily expressed on activated T cells and regulatory T cells (Tregs). CTLA-4 plays a crucial role in maintaining immune homeostasis by delivering inhibitory signals to downregulate T cell activation and proliferation. This receptor functions by binding to the ligands CD80 (B7-1) and CD86 (B7-2), which are expressed on antigen-presenting cells (APCs). By inhibiting excessive immune responses, CTLA-4 prevents autoimmunity and maintains immune tolerance to self-antigens. CTLA-4 is the first immune checkpoint to have been targeted for immunotherapy, exemplified by the development of the monoclonal antibody ipilimumab, which blocks CTLA-4 to boost anti-tumor immune responses. Given its significance in regulating immune responses, CTLA-4 is a focus of research in fields ranging from oncology to autoimmune disorders.

Related Products

EM0062

Mouse CTLA4(Cytotoxic T-Lymphocyte Associated Antigen 4) ELISA Kit

Ver Producto
FNab09937

anti- CTLA4 antibody

Ver Producto
P4807

Recombinant Human CTLA4

Ver Producto